Resverlogix Corp. (TSE:RVX – Get Free Report) shares crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.06 and traded as low as C$0.05. Resverlogix shares last traded at C$0.06, with a volume of 2,400 shares traded.
Resverlogix Stock Performance
The firm’s 50 day simple moving average is C$0.06 and its 200 day simple moving average is C$0.06. The firm has a market capitalization of C$15.23 million, a price-to-earnings ratio of -1.10 and a beta of 0.71.
Resverlogix (TSE:RVX – Get Free Report) last posted its earnings results on Tuesday, November 12th. The biotechnology company reported C($0.03) earnings per share (EPS) for the quarter. As a group, sell-side analysts forecast that Resverlogix Corp. will post -0.22 earnings per share for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Why Are These Companies Considered Blue Chips?
- What Does the Future Hold for Eli Lilly?
- The Significance of Brokerage Rankings in Stock Selection
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
